Clinical Genomics Lab Director - Hematologic Malignancies

Bionano; San Diego (CA); On-site; USD 250,000 - 430,000; Full time

Job summary

Bionano Laboratories, the RUO and CLIA/CAP services unit of Bionano Genomics, seeks a board-certified pathologist and/or laboratory geneticist with extensive experience in hematologic malignancies and genomic interpretation. The role leads laboratory oversight, sign-out of cytogenetic/molecular testing, and provides technical leadership on emerging platforms.

Responsibilities include validating plans, updating clinical tools, and engaging with regulators, payers, and guideline bodies.

Qualifications

• Requires M.D. or Ph.D. in pathology, molecular genetics, or related field.
• Board certification (or eligibility) in Laboratory Genetics and Genomics (LGG) or Clinical Cytogenetics and Genomics (ABMGG).
• Clinical Laboratory Director license appropriate for high-complexity testing, or CA-licensed physician as director.
• Maintain licensure and continuing education; attend educational events.
• Attend at least one educational conference annually for CMEs and field updates.

Responsibilities

• Oversee proficiency testing and quality reports; approve validation plans/reports.
• Interpret and sign out clinical diagnostic genomic data (OGM, CMA, NGS) with clinical context.
• Update clinical tools and reference files to improve interpretation and utility.
• Contribute to publications, conferences, and external education in hematologic malignancies.
• Interact with regulatory agencies, accrediting bodies, and payer-related groups.
• Perform additional duties as assigned.

Skills

Medical genetics

Hematologic malignancies

Laboratory oversight

Sign-out

Education

MD or PhD

Board certification eligibility LGG/ABMGG

Job description

Bionano Laboratories, the RUO and CLIA/CAP services unit of Bionano Genomics, seeks a board-certified pathologist and/or laboratory geneticist with extensive experience in hematologic malignancies and genomic interpretation. The role leads laboratory oversight, sign-out of cytogenetic/molecular testing, and provides technical leadership on emerging platforms.

Responsibilities include validating plans, updating clinical tools, and engaging with regulators, payers, and guideline bodies.